ZOTA Share Price Target 2035

CAGR-based price projection for Zota Health Care LImited (ZOTA) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (-1.6% CAGR)
Rs 1,095
2035 Target
Base Case (-4.0% CAGR)
Rs 876
2035 Target
Bull Case (-6.0% CAGR)
Rs 724
2035 Target

Current Market Snapshot

CMP: Rs 1,267.80
52W High: Rs 1,444.90
52W Low: Rs 1,028.10
1Y CAGR: -7.9%
3Y CAGR: -4.0%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,247 Rs 1,217 Rs 1,191
2028 Rs 1,227 Rs 1,168 Rs 1,119
2029 Rs 1,208 Rs 1,121 Rs 1,052
2030 Rs 1,188 Rs 1,076 Rs 988
2031 Rs 1,169 Rs 1,032 Rs 928
2032 Rs 1,150 Rs 991 Rs 872
2033 Rs 1,132 Rs 951 Rs 820
2034 Rs 1,113 Rs 913 Rs 770
2035 Rs 1,095 Rs 876 Rs 724

Other ZOTA Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the ZOTA share price target for 2035?

Based on historical growth analysis, the ZOTA share price target for 2035 ranges from Rs 1,095 (conservative) to Rs 876 (base case) to Rs 724 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of ZOTA?

The current market price of ZOTA (Zota Health Care LImited) is Rs 1,267.80. The 52-week high is Rs 1,444.90 and 52-week low is Rs 1,028.10.

Is ZOTA a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for ZOTA price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -1.6% CAGR), Base (-4.0% CAGR), and Bull (optimistic at -6.0% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.